Cargando…

ET-1 Translational research platform for malignant brain tumors

Introduction: The standard therapy for malignant brain tumors includes surgery and combination therapy with radiation and chemotherapy, but to provide individualized treatment based on the biological and molecular genetic background of the tumor, integrate genetic information with various functional...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tateishi, Kensuke, Miyake, Yohei, Nakamura, Taishi, Sasame, Jo, Hayashi, Takahiro, Oshima, Akito, Honma, Hirokuni, Ikegaya, Naoki, Yamamoto, Tetsuya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Supplement Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648230/ http://dx.doi.org/10.1093/noajnl/vdab159.014

Ejemplares similares

ET-8 Integrated diagnostic approach to predict prognosis for malignant gliomas
por: Isoda, Masataka, et al.
Publicado: (2021)

SPDR-1 HSP90 inhibition overcomes resistant to molecular targeted therapy in BRAF(V600E) mutant glioblastoma
por: Sasame, Jo, et al.
Publicado: (2021)

GEN-8 Real-time PCR based intraoperative genetic analysis for gliomas
por: Takabayashi, Katsuhiro, et al.
Publicado: (2021)

SPDR-01 Paired epithelioid glioblastoma patient-derived xenograft models to evaluate resistant mechanism for molecular target therapy
por: Sasame, Jo, et al.
Publicado: (2020)

HGG-51. PAIRED EPITHELIOID GLIOBLASTOMA PATIENT DERIVED XENOGRAFT MODELS WITH/WITHOUT MOLECULAR TARGET THERAPY
por: Sasame, Jo, et al.
Publicado: (2020)

CS-03 BRAF V600E mutation mediates FDG-methionine uptake mismatch in polymorphous low-grade neuroepithelial tumor of the young
por: Hayashi, Takahiro, et al.
Publicado: (2020)

BT-07 PATIENT DERIVED XENOGRAFT MODELS OF EPITHELIOID GLIOBLASTOMA AND THERAPEUTIC VULNERABILITY IN MOLECULAR TARGET THERAPY
por: Sasame, Jo, et al.
Publicado: (2019)

CBMS-04 Novel xenograft model to clarify tumor progressive mechanism and therapeutic target in primary central nervous system lymphoma
por: Tateishi, Kensuke, et al.
Publicado: (2020)

TB-04 TERT PROMOTER MUTATION AS A SUSCEPTIBLE MOLECULAR MARKER OF BCNU LOCAL THERAPY
por: Miyake, Shigeta, et al.
Publicado: (2019)

BRAF V600E mutation mediates FDG-methionine uptake mismatch in polymorphous low-grade neuroepithelial tumor of the young
por: Tateishi, Kensuke, et al.
Publicado: (2020)

Genetic alterations that deregulate RB and PDGFRA signaling pathways drive tumor progression in IDH2-mutant astrocytoma
por: Tateishi, Kensuke, et al.
Publicado: (2023)

Verbal and memory deficits caused by aphasic status epilepticus after resection of a left temporal lobe glioma
por: Kamogawa, Misaki, et al.
Publicado: (2021)

TB-02 NF-KB CANONICAL PATHWAY ACTIVATION DRIVES GLYCOLYSIS AND TUMOR PROGRESSION IN PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA
por: Tateishi, Kensuke, et al.
Publicado: (2019)

Superficial siderosis and nonobstructive hydrocephalus due to subependymoma in the ventricle: An illustrative case report
por: Otomo, Yuta, et al.
Publicado: (2021)

A case of midbrain germinoma: A literature review for radiographic and clinical features
por: Miyake, Yohei, et al.
Publicado: (2023)

Evaluation of Tumor Cell Infiltration to the Skull in Dermatofibrosarcoma Protuberans of the Scalp: Case Report and Literature Review
por: HONGO, Takeshi, et al.
Publicado: (2021)

Thiel’s embalming method with additional intra-cerebral ventricular formalin injection (TEIF) for cadaver training of head and brain surgery
por: Miyake, Shigeta, et al.
Publicado: (2020)

Thigh leiomyosarcoma-derived brain metastasis with intracerebral hematoma: A case report and literature review
por: Oka, Chihiro, et al.
Publicado: (2023)

IMT-1 A translational research for practical use of dendritic cell-based immunotherapy against malignant glioma
por: Akasaki, Yasuharu, et al.
Publicado: (2021)

ET-7 EVALUATION OF HYPOXIA-TARGETING RADIOPHARMACEUTICAL(64)CU-ATSM FOR PET MONITORING WITH LOCAL THERAPY IN HIGH-GRADE GLIOMA MODEL
por: Yoshii, Yukie, et al.
Publicado: (2022)

The Usefulness of Straight Chemotherapy for Dermal Exposed Anaplastic Lymphoma Kinase Fusion-Positive Anaplastic Large-Cell Lymphoma with Intracranial Invasion
por: Abe, Hiroyuki, et al.
Publicado: (2019)

Measuring health promotion: translating science into policy
por: Griffiths, James C., et al.
Publicado: (2020)

Translating knowledge from Pakistan's second generation surveillance system to other global contexts
por: Adrien, Alix, et al.
Publicado: (2013)

ET-6 Gemcitabine radiosensitization primes irradiated malignant meningioma cells for senolytic elimination by navitoclax
por: Yamamoto, Masahiro, et al.
Publicado: (2021)

NI-2 Use of neurite orientation dispersion and density imaging(NODDI)for early distinction between infiltrating tumor and vasogenic edema in non-enhancing lesions with glioblastoma patients
por: Okita, Yoshiko, et al.
Publicado: (2021)

ET-03 Convection-enhanced delivery of EZH2 inhibitor for the treatment of diffuse midline glioma
por: Sasaki, Takahiro, et al.
Publicado: (2020)

IM-8 Significance of IL-1 pathways in Glioblastoma
por: Kai, Keitaro, et al.
Publicado: (2021)

ET-06 Suppression of glioblastoma through novel drug based on “Gene Switch Technology”
por: Yamamoto, Etsuko, et al.
Publicado: (2020)

ML-15 The future direction of treatment development for primary central nervous system lymphoma (PCNSL)
por: Shinojima, Naoki, et al.
Publicado: (2020)

ET-7 Roles for hENT1 and dCK in gemcitabine sensitivity and malignancy of meningioma
por: Yamamoto, Masahiro, et al.
Publicado: (2021)

ML-20 Outcome of high-dose methotrexate-based chemotherapy with or without Rituximab for primary central nervous system lymphoma
por: Takezaki, Tatsuya, et al.
Publicado: (2020)

NI-14 estimation of property of MRI non-contrast enhanced lesion of Glioblastoma using T1/T2 ratio
por: Yamamoto, Shota, et al.
Publicado: (2021)

CBMS-12 Pro renin receptor antibody regulates glioblastoma stemness
por: Fujimori, Takeshi, et al.
Publicado: (2020)

MET-3 A Case of Intrapituitary Adenoma Metastasis from Advanced gastric cancer
por: Fujita, Shohei, et al.
Publicado: (2021)

Blood platelets as an RNA biomarker platform for neuro-oncological diseases
por: Post, Edward, et al.
Publicado: (2022)

Association between Food Group Intake and Serum Total Cholesterol in the Japanese Population: NIPPON DATA 80/90
por: Kondo, Imako, et al.
Publicado: (2010)

COT-08 Analysis of prognosis of biopsy/partial resection cases of malignant glioma
por: Yamamoto, Yohei, et al.
Publicado: (2020)

Mortality in the JACC Study till 1999
por: Watanabe, Yoshiyuki, et al.
Publicado: (2005)

CLRM-01 SUMMARY OF VIRTUAL TUMOR BOARD PLATFORMS AND IMPLEMENTATION IN NEURO-ONCOLOGY
por: Ekhator, Chukwuyem, et al.
Publicado: (2022)

NI-3 Magnetic resonance relaxometry for tumor cell density imaging for glioma: An exploratory study via 11C-methionine PET and its validation via stereotactic tissue sampling
por: Kinoshita, Manabu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a4qbkerpfcfl6gofod1e5jggrk